Zhejiang Hisoar Pharmaceutical Co., Ltd.

SZSE:002099 주식 보고서

시가총액: CN¥9.4b

Zhejiang Hisoar Pharmaceutical 과거 수익 실적

과거 기준 확인 0/6

Zhejiang Hisoar Pharmaceutical's earnings have been declining at an average annual rate of -72.6%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 5.4% per year.

주요 정보

-72.6%

수익 성장률

-74.1%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률-5.4%
자기자본 수익률-6.8%
순이익-19.0%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Price Is Out Of Tune With Revenues

Sep 27
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Price Is Out Of Tune With Revenues

Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?

Aug 30
Does Zhejiang Hisoar Pharmaceutical (SZSE:002099) Have A Healthy Balance Sheet?

Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?

May 27
Zhejiang Hisoar Pharmaceutical (SZSE:002099) Has Debt But No Earnings; Should You Worry?

Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Shares Climb 28% But Its Business Is Yet to Catch Up

Mar 03
Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) Shares Climb 28% But Its Business Is Yet to Catch Up

수익 및 비용 분석

Zhejiang Hisoar Pharmaceutical 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SZSE:002099 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 241,940-369335120
30 Jun 242,014-401343117
31 Mar 242,066-430337115
31 Dec 232,172-420332116
30 Sep 232,310-158301129
30 Jun 232,433-64342136
31 Mar 232,53443383141
01 Jan 232,70488425145
30 Sep 222,765226466149
30 Jun 222,764206518154
31 Mar 222,647125522159
01 Jan 222,48595574165
30 Sep 212,31034558166
30 Jun 212,352115527153
31 Mar 212,538272484146
31 Dec 202,471320465132
30 Sep 202,518443444123
30 Jun 202,517541409123
31 Mar 202,685673408118
31 Dec 192,941771394123
30 Sep 193,030812407122
30 Jun 193,085825408119
31 Mar 192,940763416117
31 Dec 182,719605371111
30 Sep 182,651540368118
30 Jun 182,447375304167
31 Mar 182,335271297139
31 Dec 172,309342323114
30 Sep 172,2517638877
30 Jun 172,3761654770
31 Mar 172,3762085110
31 Dec 162,4342255080
30 Sep 162,4935004690
30 Jun 162,4754894700
31 Mar 162,4864894670
31 Dec 152,4645174680
30 Sep 152,3554964640
30 Jun 152,0363783790
31 Mar 151,6692113100
31 Dec 141,319542590
30 Sep 141,158-512200
30 Jun 141,126-772240
31 Mar 141,135-822230
31 Dec 131,161-822110

양질의 수익: 002099 is currently unprofitable.

이익 마진 증가: 002099 is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 002099 is unprofitable, and losses have increased over the past 5 years at a rate of 72.6% per year.

성장 가속화: Unable to compare 002099's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: 002099 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-1.2%).


자기자본 수익률

높은 ROE: 002099 has a negative Return on Equity (-6.81%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기